CBD and Metabolic Syndromes

Peer-reviewed studies into the potential effects of Cannabidiol and Metabolic Syndromes

On this page, CBD and Metabolic Syndromes, you will find research pertaining to the use of Cannabidiol and Cannabinoids and its possible effects on Metabolic Syndromes The information below is not meant to influence your opinion, but rather give you access to a wealth of scientific literature in an attempt to make and educated and informed choice. Click Here to see all of the conditions that have been researched alongside CBD and Metabolic Syndromes.

The Impact of Marijuana Use on Glucose, Insulin, and Insulin Resistance among US Adults

From the abstract:

There are limited data regarding the relationship between cannabinoids and metabolic processes. Epidemiologic studies have found lower prevalence rates of obesity and diabetes mellitus in marijuana users compared with people who have never used marijuana, suggesting a relationship between cannabinoids and peripheral metabolic processes… We found that marijuana use was associated with lower levels of fasting insulin and HOMA-IR, and smaller waist circumference.

The potential use of cannabidiol in the therapy of metabolic syndrome

From the abstract:

Cannabidiol, a cannabinoid and serotonin receptor antagonist, may alleviate hyperphagia without the side effects of rimonabant (for example depression and reduced insulin sensitivity). Similar to the peroxisome proliferator-activated receptor-gamma agonists, it may also help the differentation of adipocytes. Cannabidiol has an immunomodulating effect, as well, that helps lessen the progression of atherosclerosis induced by high glucose level. It may also be effective in fighting ischaemic diseases, the most harmful complications of metabolic syndrome.

Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes.

From the abstract:

…evidence is emerging that some nonpsychotropic plant cannabinoids, such as cannabidiol, can be employed to retard β-cell damage in type 1 diabetes. These novel aspects of endocannabinoid research are reviewed in this chapter, with emphasis on the biological effects of plant cannabinoids and endocannabinoid receptor antagonists in diabetes.